ALLMEDTECH.COM
ALLMEDTECH.COM
MEDICAL, SURGICAL, DENTAL,
PHARMACEUTICALS , OBGYN,
VETERINARY & PET SUPPLIES,
DIAGNOSTIC LAB, COSMETICS,
VACCINES , INJECTABLES , IV ,
GENERIC & OTC MEDICATIONS ,
PHARMACY'S AND MED-SPORT
SUPPLIES & EQUIPMENTS
TOLL FREE: 1-800-939-6944
Calvenza-03 EIV/EHV Vaccine
20 ml (10 Doses)
BOEHRINGER INGELHEIM 139136
20 ml (10 Doses)
BOEHRINGER INGELHEIM 139136
Product Description
Calvenza-03 EIV/EHV Vaccine
20 ml (10 Doses)
BOEHRINGER INGELHEIM 139136
Specifications Selling Unit of Measure: Each Doses Per Unit: 10 Doses Biological Type: Killed Reconstitution Required: N Color Of Medicine: Opaque Container Type: High Density Plastic Bottle Volume: 20 ml Delivery Type: Injection Presentation: Liquid Diseases Indicated For: Equine herpesvirus Type 1, Equine herpesvirus Type 4, Equine influenza virus A2 North American, Equine influenze virus A2 Eurasian
Product Details For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory disease due to equine herpesvirus type 1 (EHV-1) and type 4 (EVH-4) and by equine influenza type A2 virus.
Benefits: Incorporates the latest emerging North American EIV strain (Ohio/2003), as well as an established North American EIV strain (Kentucky/2/95) Also incorporates a relevant Eurasian EIV strain (Newmarket/2/93) Unique EHV-1 equine respiratory origin isolate Minimal vaccine site reactions Three dose regiment conforms to AAEP recommendations Safe, all killed vaccine
20 ml (10 Doses)
BOEHRINGER INGELHEIM 139136
Specifications Selling Unit of Measure: Each Doses Per Unit: 10 Doses Biological Type: Killed Reconstitution Required: N Color Of Medicine: Opaque Container Type: High Density Plastic Bottle Volume: 20 ml Delivery Type: Injection Presentation: Liquid Diseases Indicated For: Equine herpesvirus Type 1, Equine herpesvirus Type 4, Equine influenza virus A2 North American, Equine influenze virus A2 Eurasian
Product Details For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory disease due to equine herpesvirus type 1 (EHV-1) and type 4 (EVH-4) and by equine influenza type A2 virus.
Benefits: Incorporates the latest emerging North American EIV strain (Ohio/2003), as well as an established North American EIV strain (Kentucky/2/95) Also incorporates a relevant Eurasian EIV strain (Newmarket/2/93) Unique EHV-1 equine respiratory origin isolate Minimal vaccine site reactions Three dose regiment conforms to AAEP recommendations Safe, all killed vaccine
Accessories
 Regular price: $25.00 Sale price: $22.99 |  Regular price: $225.00 Sale price: $199.99 |